Influenza susceptibility, severity, and shedding in HIV-infected adults: A review of the literature

Clinical Infectious Diseases

Volumn 52, Issue 2, 2011, Pages 219-227

  Sheth, Anandi N ^a   Althoff, Keri N ^b   Brooks, John T ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; OSELTAMIVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIOPHAGE; COMORBIDITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VIRUS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; REVIEW; SEASON; VACCINATION; VIRUS INFECTION; VIRUS SHEDDING;

ADULT; DISEASE SUSCEPTIBILITY; HIV INFECTIONS; HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; SEVERITY OF ILLNESS INDEX; VIRUS SHEDDING;

EID: 79951847361     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq110     Document Type: Review

References (52)

1. Beck JM, Rosen MJ, Peavy HH. Pulmonary complications of HIV infection. Report of the fourth NHLBI workshop. Am J Respir Crit Care Med 2001;164:2120-6. (Pubitemid 34020255)
2. Klein MB, Lu Y, Del Balso L, Cote S, Boivin G. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis 2007;45:234-40. (Pubitemid 47041016)
3. Maldarelli F, McPhee J, Ellner P, Neu H. Influenza in HIV-exposed adults. Clin Res 1988;36:800A.
4. Cohen JP, Macauley C. Susceptibility to influenza A in HIV-positive patients. JAMA 1989;261:245.
5. Fine AD, Bridges CB, De Guzman AM, et al. Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. Clin Infect Dis 2001;32:1784-91. (Pubitemid 32532009)
6. Boschini A, Longo B, Caselli F, et al. An outbreak of influenza in a residential drug-rehabilitation community. J Med Virol 2006;78:1218-22. (Pubitemid 44182239)
7. Tasker SA, O'Brien WA, Treanor JJ, et al. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. Vaccine 1998;16:1039-42. (Pubitemid 28276020)
8. Yamanaka H, Teruya K, Tanaka M, et al. Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients. J Acquir Immune Defic Syndr 2005;39:167-73. (Pubitemid 40741114)
9. Ranieri R, Veronelli A, Santambrogio C, Pontiroli AE. Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients. AIDS Res Hum Retroviruses 2005;21:407-9. (Pubitemid 40800457)
10. UNAIDS. Report on the global AIDS epidemic 2008: HIV AIDS estimates and data, 2007 and 2001. Available at: http://data.unaids.org/pub/GlobalReport/2008/ jc1510-2008-global-report-pp211-234-en.pdf. Last accessed 1 October 2010.
11. Oliveira W, Carmo E, Penna G, et al. Pandemic H1N1 influenza in Brazil: analysis of the first 34, 506 notified cases of influenza-like illness with severe acute respiratory infection (SARI). Euro Surveill 2009;14: pi519362.
12. Gilsdorf A, Poggensee G. Influenza A (H1N1) v in Germany: the first 10, 000 cases. Euro Surveill 2009;14: pi519318.
13. Campos-Loza A, Soto-Ramirez L, Sierra-Madero J, et al. New swine origin influenza A in HIV-infected patients during the 2009 outbreak in Mexico City [abstract]. In: 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, 2010: #801. Available at: http://www.retroconference.org/ 2010/PDFs/801.pdf. Last accessed 1 October 2010.
14. Martinez E, Marcos M, Hoyo I, et al. 2009 H1N1 virus infection in HIV1 adults [abstract]. In: 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, 2010: #802LB. Available at: http://www. retroconference.org/2010/PDFs/802LB.pdf. Last accessed 1 October 2010.
15. Althoff K, Gange S, Sharp G. Elevated 2009 H1N1 antibody titers in HIV-infected and uninfected women in the US: a sero-study, March 1 to September 30, 2009 [abstract]. In: 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, 2010: #807LB. Available at: http://www. retroconference.org/2010/PDFs/807LB.pdf Last accessed 1 October 2010.
16. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004;164:2206-16. (Pubitemid 39452980)
17. Radwan HM, Cheeseman SH, Lai KK, Ellison IR. Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season. Clin Infect Dis 2000;31:604-6. (Pubitemid 32289599)
18. Thurn JR, Henry K. Influenza A pneumonitis in a patient infected with the human immunodeficiency virus (HIV). Chest 1989;95:807-10. (Pubitemid 19102887)
19. Markson LE, Turner BJ, Fanning TR. Duration of Medicaid AIDS hospitalizations-variation by season, stage, and year. Am J Public Health 1992;82:578-80.
20. Safrin S, Rush JD, Mills J. Influenza in patients with human immunodeficiency virus infection. Chest 1990;98:33-7. (Pubitemid 20223662)
21. CDC. Increase in pneumonia mortality among young adults and the HIV epidemic-New York City, United States. MMWR Morb Mortal Wkly Rep 1988;37:593-6.
22. Neuzil KM, Reed GW, Mitchel EF Jr., Griffin MR. Influenza-associated morbidity and mortality and in young and middle-aged women. JAMA 1999;281:901-7. (Pubitemid 29124633)
23. Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Archive Intern Med 2001;161:441-6. (Pubitemid 32116562)
24. Skiest DJ, Kaplan P, Machala T, Boney L, Luby J. Clinical manifestations of influenza in HIV-infected individuals. Int J STD AIDS 2001;12:646-50. (Pubitemid 32964348)
25. Neuzil KM, Coffey CS, Mitchel EF Jr, Griffin MR. Cardiopulmonary hospitalizations during influenza season in adults and adolescents with advanced HIV infection. J Acquir Immune Defic Syndr 2003;34:304-7. (Pubitemid 37377365)
26. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44.
27. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009;302:1872-9.
28. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009;302:1896-902.
29. Fuhrman C, Bonmarin I, Paty A, et al. Severe hospitalised 2009 pandemic influenza A (H1N1) cases in France, 1 July - 15 November 2009. Euro Surveill 2010;15: pii=19463.
30. Thouillot F, Do C, Balleydier E, et al. Preliminary analysis of the pandemic H1N1 influenza on Reunion Island (Indian Ocean): surveillance trends (July to mid-September 2009). Euro Surveill. 2009;14: pii519364.
31. Cullen G, Martin J, O'Donnell J, et al. Surveillance of the first 205 confirmed hospitalized cases of pandemic H1N1 influenza in Ireland, 28 April - 3 October 2009. Euro Surveill 2009;14: pii=19389.
32. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009;302:1880-7.
33. Cortés JM, Gómez LP, Morilla EP, et al. Behavior of the pandemic H1N1 influenza virus in Andalusia, Spain, at the onset of the 2009-10 season. Euro Surveill 2009;14: pii=19433.
34. van't Klooster TM, Wileders C, Donker T, et al. Surveillance of hospitalisations for 2009 pandemic influenza (H1N1) in the Netherlands, 5 June - 31 December 2009. Euro Surveill 2010;15: pii=19461.
35. Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009;14: pi=19309.
36. Gomez J, Munayco C, Arrasco J, et al. Pandemic influenza in a southern hemisphere setting: the experience in Peru from May to September, 2009. Euro Surveill 2009;14: pii=19371.
37. Nguyen TQ, Gwynn RC, Kellerman SE, et al. Population prevalence of reported unreported HIV and related behaviors among the household adult population in New York City, 2004. AIDS 2008;22:281-7.
38. Lee EH, Wu C, Lee EU, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 2010;50:1498-504.
39. Reyes-Terán G, de la Rosa-Zamboni D, Ormsby C, et al. Clinical features of subjects infected with HIV and H1N1 influenza virus [abstract]. In: 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, 2010: #803LB. Available at: http://www.retroconference.org/2010/PDFs/803LB.pdf. Last accessed 1 October 2010.
40. Isais F, Lye D, Llorin R, et al. Pandemic (H1N1) 2009 influenza HIV-infected adults: clinical features severity and outcome. J Infect 2010;61:437-440.
41. Lee N, Chan PKS, Hui DSC, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009;200:492-500.
42. Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999;282:1240-6. (Pubitemid 29468495)
43. Klimov AI, Rocha E, Hayden FG, Shult PA, Roumillat LF, Cox NJ. Prolonged shedding of amantadine-resistant influenza A viruses by immunodeficient patients: detection by polymerase chain reactionrestriction analysis. J Infect Dis 1995;172:1352-5.
44. Boivin G, Goyette N, Bernatchez H. Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient. Clin Infect Dis 2002;34: E23-E5.
45. Weinstock D, Gubareva L, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003;348:867-8. (Pubitemid 36245772)
46. Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 2006;193:760-4.
47. Gooskens J, Jonges M, Claas EC, Meijer A, Kroes AC. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009;199:1435-41.
48. CDC. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009;58:893-6.
49. Hill-Cawthorne GA, Schelenz S, Lawes M, Dervisevic S. Oseltamivirresistant pandemic (H1N1) 2009 in patient with impaired immune system. Emerg Infect Dis 2010;16:1185-6.
50. King JC Jr, Treanor J, Fast PE, et al. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis 2000;181:725-728. (Pubitemid 30131847)
51. Peters PJ, Skarbinski J, Louie JK, et al. HIV-infected hospitalized patients with 2009 pandemic influenza A (pH1N1) - United States, spring and summer 2009. Clin Infect Dis 2010;52(s1):S183-S188.
52. Stopka T, Molitor F, Ruiz J. Modeling HIV prevalence estimates in California [abstract 155023]. In: 135th American Public Health Association Annual Meeting. Washington, DC, 2007. Available at: http://apha.confex.com/ recording/apha/135am/pdf/free/4db77adf5df9fff0d3-caf5cafe28f496/paper155023-1. pdf. Last accessed 1 October 2010.